These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38262608)

  • 1. My host's enemy is my enemy: plasmids carrying CRISPR-Cas as a defence against phages.
    Siedentop B; Rüegg D; Bonhoeffer S; Chabas H
    Proc Biol Sci; 2024 Jan; 291(2015):20232449. PubMed ID: 38262608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Different Target Sequences on Type III CRISPR-Cas Immunity.
    Maniv I; Jiang W; Bikard D; Marraffini LA
    J Bacteriol; 2016 Jan; 198(6):941-50. PubMed ID: 26755632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coevolution between bacterial CRISPR-Cas systems and their bacteriophages.
    Watson BNJ; Steens JA; Staals RHJ; Westra ER; van Houte S
    Cell Host Microbe; 2021 May; 29(5):715-725. PubMed ID: 33984274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unveil the Secret of the Bacteria and Phage Arms Race.
    Wang Y; Fan H; Tong Y
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the CRISPR-Cas system in bacteriophages active on epidemic strains of Vibrio cholerae in Bangladesh.
    Naser IB; Hoque MM; Nahid MA; Tareq TM; Rocky MK; Faruque SM
    Sci Rep; 2017 Nov; 7(1):14880. PubMed ID: 29093571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas immunity leads to a coevolutionary arms race between Streptococcus thermophilus and lytic phage.
    Common J; Morley D; Westra ER; van Houte S
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180098. PubMed ID: 30905285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of Acr-mediated immunosuppression in
    Pons BJ; Westra ER; van Houte S
    MethodsX; 2023; 10():101941. PubMed ID: 36504499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ecology and evolution of phages encoding anti-CRISPR proteins.
    Pons BJ; van Houte S; Westra ER; Chevallereau A
    J Mol Biol; 2023 Apr; 435(7):167974. PubMed ID: 36690071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keeping crispr in check: diverse mechanisms of phage-encoded anti-crisprs.
    Trasanidou D; Gerós AS; Mohanraju P; Nieuwenweg AC; Nobrega FL; Staals RHJ
    FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31077304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. It is unclear how important CRISPR-Cas systems are for protecting natural populations of bacteria against infections by mobile genetic elements.
    Westra ER; Levin BR
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):27777-27785. PubMed ID: 33122438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why put up with immunity when there is resistance: an excursion into the population and evolutionary dynamics of restriction-modification and CRISPR-Cas.
    Gurney J; Pleška M; Levin BR
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180096. PubMed ID: 30905282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Rcs stress response inversely controls surface and CRISPR-Cas adaptive immunity to discriminate plasmids and phages.
    Smith LM; Jackson SA; Malone LM; Ussher JE; Gardner PP; Fineran PC
    Nat Microbiol; 2021 Feb; 6(2):162-172. PubMed ID: 33398095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in the durability of CRISPR-Cas immunity.
    Chabas H; Nicot A; Meaden S; Westra ER; Tremblay DM; Pradier L; Lion S; Moineau S; Gandon S
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180097. PubMed ID: 30905283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage-Encoded Anti-CRISPR Defenses.
    Stanley SY; Maxwell KL
    Annu Rev Genet; 2018 Nov; 52():445-464. PubMed ID: 30208287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different genetic and morphological outcomes for phages targeted by single or multiple CRISPR-Cas spacers.
    Watson BNJ; Easingwood RA; Tong B; Wolf M; Salmond GPC; Staals RHJ; Bostina M; Fineran PC
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180090. PubMed ID: 30905290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revealing bacteria-phage interactions in human microbiome through the CRISPR-Cas immune systems.
    Monshizadeh M; Zomorodi S; Mortensen K; Ye Y
    Front Cell Infect Microbiol; 2022; 12():933516. PubMed ID: 36250060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas10 assisted editing of virulent staphylococcal phages.
    Nayeemul Bari SM; Hatoum-Aslan A
    Methods Enzymol; 2019; 616():385-409. PubMed ID: 30691652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploitation of the Cooperative Behaviors of Anti-CRISPR Phages.
    Chevallereau A; Meaden S; Fradet O; Landsberger M; Maestri A; Biswas A; Gandon S; van Houte S; Westra ER
    Cell Host Microbe; 2020 Feb; 27(2):189-198.e6. PubMed ID: 31901522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems.
    Hwang S; Maxwell KL
    CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dairy phages escape CRISPR defence of Streptococcus thermophilus via the anti-CRISPR AcrIIA3.
    Pastuszka A; Rousseau GM; Somerville V; Levesque S; Fiset JP; Goulet A; Doyon Y; Moineau S
    Int J Food Microbiol; 2023 Dec; 407():110414. PubMed ID: 37778080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.